Literature DB >> 32248020

Alterations in peripheral blood B cells in systemic lupus erythematosus patients with renal insufficiency.

Anna Wardowska1, Michał Komorniczak2, Aneta Skoniecka3, Barbara Bułło-Piontecka2, Katarzyna A Lisowska4, M Alicja Dębska-Ślizień2, Michał Pikuła3.   

Abstract

OBJECTIVE: Systemic lupus erythematosus (SLE) is one of the autoimmune diseases, believed to be closely related to hyperactivity of B cells, overproduction of autoantibodies and immune complex formation and deposition in affected tissue. The autoreactive inflammation leads to multiorgan damage with kidney dysfunction in the forefront. Studies on lupus nephritis (LN), affecting the majority of SLE patients, are mainly focused on cells causing local inflammation. The aim of our work was to detect alterations in more accessible peripheral blood B cells in the course of SLE focusing on the influence of renal insufficiency (RI) on those parameters.
METHODS: We performed a comprehensive flow cytometry analysis of B cell subpopulations, analyzed gene expression patterns with qPCR, and examined serum cytokine levels with multiplex cytokine/chemokine assay.
RESULTS: We discovered distribution of specific B cell subsets, especially CD38+ cells, plasmablasts, associated with the presence and severity of the disease. Changes in expression of MBD2, DNMT1 and APRIL genes were not only associated with activity of SLE but also were significantly changed in patients with RI.
CONCLUSIONS: All these results shed new light on the role of circulating B cells, their subpopulations, function, and activity in the SLE with kidney manifestation.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  B cells; Flow cytometry; Gene expression; Renal insufficiency; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2020        PMID: 32248020     DOI: 10.1016/j.intimp.2020.106451

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  3 in total

1.  CD11c+ T-bet+ CD21hi B Cells Are Negatively Associated With Renal Impairment in Systemic Lupus Erythematosus and Act as a Marker for Nephritis Remission.

Authors:  Víctor A Sosa-Hernández; Sandra Romero-Ramírez; Rodrigo Cervantes-Díaz; Daniel A Carrillo-Vázquez; Itze C Navarro-Hernandez; Laura P Whittall-García; Abdiel Absalón-Aguilar; Ana S Vargas-Castro; Raúl F Reyes-Huerta; Guillermo Juárez-Vega; David E Meza-Sánchez; Vianney Ortiz-Navarrete; Jiram Torres-Ruiz; Nancy R Mejía-Domínguez; Diana Gómez-Martín; José L Maravillas-Montero
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

Review 2.  CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity.

Authors:  Zayda L Piedra-Quintero; Zachary Wilson; Porfirio Nava; Mireia Guerau-de-Arellano
Journal:  Front Immunol       Date:  2020-11-30       Impact factor: 7.561

Review 3.  The Role of B1 Cells in Systemic Lupus Erythematosus.

Authors:  Zhou She; Cuifang Li; Feifeng Wu; Jueyi Mao; Min Xie; Marady Hun; Amin Sheikh Abdirahman; Senlin Luo; Wuqing Wan; Jidong Tian; Chuan Wen
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.